comparemela.com

Latest Breaking News On - Boehringer ingelheim venture fund gmb - Page 1 : comparemela.com

smartbax Announces Seed Financing of €1 2 Million to Develop Next-generation Antibiotics

smartbax, a biotech company developing next-generation antibiotics against multi-drug resistant bacteria, today announced the close of its seed financing round of €1.2 million from Boehringer Ingelheim

San franciscoUnited statesHong kongEric juskewitzRobert macsicsGewinn nurStephan sieberAngelika vlachouSebastian kreuzMarco janezicBoehringer ingelheim venture fund gmbMinistry for economic affairsBavarian ministry of economic affairsTechnical university of munichTrophic communicationsFraunhofer society

Aignostics Raises €14m Series A to Advance AI-powered Pathology

Oversubscribed financing round with top-tier life science investors, led by Wellington Partners Spin-off from Charité – Universitätsmedizin Berlin developing

United statesNew zealand generalNew zealandMaximilian alberRainer strohmengerJohannes fischerAlexander ehlgenFrederick klauschenOxford immunotecViktor matyasRoche ventanaEuropean regional development fundDigital health acceleratorBerlin institute of healthBoston scientificBoehringer ingelheim venture fund

Aignostics Raises €14m Series A to Advance AI-powered

Oversubscribed financing round with top-tier life science investors, led by Wellington PartnersSpin-off from Charité – Universitätsmedizin Berlin.

United statesNew zealand generalNew zealandKaja skorkaMaximilian alberRegina lutzRainer strohmengerJohannes fischerAlexander ehlgenFrederick klauschenOxford immunotecViktor matyasRoche ventanaAignostics gmbMc servicesEuropean regional development fund

Hong Kong Science and Technology Parks Corporation: HKSTP and Boehringer Ingelheim Venture Fund Launch Co-Incubation Programme to Fast-track R&D in Infectious Diseases and Immunology

Hong Kong Science and Technology Parks Corporation (HKSTP) is partnering global research-driven biopharmaceutical leader, Boehringer Ingelheim Venture Fund Limited (BIVF) in a strategic co-incubation

Yuen longHong kong generalHong kongKarmen cheungFrank kalkbrennerFelix gutscheTseung kwanGuangdong hong kongAlbert wongBio commsTechnology parks corporationVenture fundHead of instituteBoehringer ingelheimIncu bio programmeBusiness development licensing

Boehringer Ingelheim Venture Fund GmbH, Novo Holdings REPAIR Impact Fund and Evotec SE complete lead Series A investment in Centauri Therapeutics Limited

Boehringer Ingelheim Venture Fund GmbH, Novo Holdings REPAIR Impact Fund and Evotec SE complete lead Series A investment in Centauri Therapeutics Limited

Rheinland pfalzUnited kingdomCity ofKenny walker durrantTim wordenSophie mcgrathAnjlee sakariaHeidi fitchettLucy sharplesCurtis mccluskeyMegan gibsonCambridge life sciencesBoehringer ingelheim corporationImpact fund novoInfective resistance impact fundBoehringer ingelheim venture fund gmb

vimarsana © 2020. All Rights Reserved.